Evidence map›Paper›PMID 40990540›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Everyday functioning in young onset dementia: differences between diagnostic groups.

Emma Weltings, Merel C Postema, Maureen van Dam, Mark A Dubbelman, Mukrabe E Tewolde, Flora H Duits, Afina W Lemstra, LEADS consortium, Bradford C Dickerson, Maria C Carrillo and 6 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Everyday functioning in young onset dementia: differences between diagnostic groups.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Emma WeltingsAlzheimer Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.ORCID 0009-0008-9031-0817
Merel C PostemaAlzheimer Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Maureen van DamAlzheimer Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Mark A DubbelmanCenter for Alzheimer Research and Therapy, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Mukrabe E TewoldeAlzheimer Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Flora H DuitsAlzheimer Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Afina W LemstraAlzheimer Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
LEADS consortium
Bradford C DickersonDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Maria C CarrilloMedical & Scientific Relations Division, Alzheimer's Association, Chicago, Illinois, USA.
Gil D RabinoviciDepartment of Neurology, University of California - San Francisco, San Francisco, California, USA.
Dustin B HammersDepartment of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Wiesje M Van der FlierAlzheimer Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Liana G ApostolovaDepartment of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Yolande A L PijnenburgAlzheimer Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Sietske A M SikkesAlzheimer Center Amsterdam, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
NATIONAL ALZHEIMERS COORDINATING CENTER (NACC)U01AG016976 · NIA · UNIVERSITY OF WASHINGTON · PI KUKULL, WALTER ANTHONY · 1999 to 2020
$72.8M
Early Onset AD Consortium - the LEAD Study (LEADS)U01AG057195 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI APOSTOLOVA, LIANA G, CARRILLO, MARIA C · 2018 to 2023
$70.3M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 1985 to 2019
$52.1M
Satellite Diagnostic and Treatment Clinic CoreP50AG008702 · NIA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI DE JAGER, PHILIP L · 1989 to 2019
$46.3M
'T V ASSESSMENT - MEMORY DISORDERED PATIENTS'P50AG005146 · NIA · JOHNS HOPKINS UNIVERSITY · PI BANDEEN-ROCHE, KAREN J. · 1985 to 2019
$37.6M
Research Education ComponentP30AG010133 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 1991 to 2020
$37.3M
Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Katherine P Rankin · 2019 to 2026
$36.9M
Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Christine S Ritchie · 2019 to 2026
$36.5M
UPenn ADCC Biomarker CoreP30AG010124 · NIA · UNIVERSITY OF PENNSYLVANIA · PI VAN DEERLIN, VIVIANNA M · 1991 to 2020
$35.1M
Neuropathology CoreP30AG013854 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI VASSAR, ROBERT J · 1996 to 2020
$28.9M
Research Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI Susan Lynn Stark · 2020 to 2026
$28.7M
ALLEO LabsAlzheimer's Association AARG-22-926940Alzheimer's Association LDRFP-21-818464Alzheimer's Association LEADSGENETICS-19-639372Cambridge CogntitionHersenstichtingNational Institute of Aging U01AG6057195Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) KICH1.GZ02.20.004NIA NIH HHS K23 AG080071NIA NIH HHS K23AG080071NIA NIH HHS P30 AG010124NIA NIH HHS P30AG010124NIA NIH HHS P30 AG010133NIA NIH HHS P30AG010133NIA NIH HHS P30 AG013854NIA NIH HHS P30AG013854NIA NIH HHS P30 AG062421NIA NIH HHS P30AG062421NIA NIH HHS P30 AG062422NIA NIH HHS P30AG062422NIA NIH HHS P30 AG066444NIA NIH HHS P30 AG066506NIA NIH HHS P30AG066506NIA NIH HHS P30 AG072976NIA NIH HHS P50 AG005146NIA NIH HHS P50AG005146NIA NIH HHS P50 AG005681NIA NIH HHS P50AG005681NIA NIH HHS P50 AG008702NIA NIH HHS P50AG008702NIA NIH HHS P50 AG023501NIA NIH HHS P50AG023501NIA NIH HHS P50 AG025688NIA NIH HHS P50AG025688NIA NIH HHS P50 AG047366NIA NIH HHS P50AG047366NIA NIH HHS R56 AG057195NIA NIH HHS R56AG057195NIA NIH HHS U01 AG016976NIA NIH HHS U01AG016976NIA NIH HHS U01 AG057195NIA NIH HHS U24 AG021886NIA NIH HHS U24AG021886Team Alzheimer
6 · The paper itself

Abstract

backgroundThe aim of this study was to examine differences in Instrumental Activities of Daily Living (IADL) among young-onset dementia (YOD) diagnoses.

methodsParticipants were included from Amsterdam Dementia and Longitudinal Early-Onset Alzheimer's Disease (LEADS) cohorts, with diagnoses of typical Alzheimer's disease (AD), behavioral variant frontotemporal dementia (bvFTD), primary progressive aphasia (PPA), posterior cortical atrophy (PCA), or dementia with Lewy bodies (DLB) established in multidisciplinary meetings. We compared overall IADL scores and item level scores between groups using multiple regression analyses, adjusted for cohort, demographics, and disease severity.

resultsWe included 582 YOD patients (58.4 ± 4.2 years; 59%F), with overall moderate IADL problems (47.5 ± 8.57). DLB patients showed the most IADL difficulties (41.8 ± 7.8) compared to PCA, typical AD, bvFTD, and PPA (adjusted β range 4.62 to 14.14, all p < 0.01), whereas PPA patients showed the least IADL difficulties (55.8 ± 9.83), with item-specific differences.

conclusionWe found differences in everyday functioning between YOD types. Understanding IADL in YOD types will assist in care planning. HIGHLIGHTS: Patients with DLB showed the most IADL difficulties compared to PCA, typical AD, bvFTD, and PPA Patients with PPA showed the least IADL difficulties compared to DLB, PCA, typical AD, and bvFTD We identified diagnostic group-specific activity challenges. While 'working' was among the most commonly impaired activities across al groups, distinct functional challenges emerged per diagnosis: for example, DLB had high impairment in financial tasks, PCA patients in visual-spatial tasks, and bvFTD with planning and organizational activities (e.g. making appointments).

Indexed as

Activities of Daily LivingAlzheimer DiseaseDementiaFrontotemporal DementiaAgedAge of OnsetAphasia, Primary ProgressiveCohort StudiesFemaleHumansLewy Body DiseaseLongitudinal StudiesMaleMiddle AgedNeuropsychological Testsalzheimer's diseaseamsterdam IADL questionnairebehavioral variant frontotemporal dementiadementia with lewy bodiesposterior cortical atrophyprimary progressive aphasiayoung onset dementia

Identifiers

PMID40990540
PMCPMC12458908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.